1659-097X

1659-097X

S1659-097X2025000200043

10.15359/mhs.22-2.20488

Mexico

Mexico

Mexico

España

Mexico

00 12 2025

00 12 2025

22 2 43 63

2022 42 3 3

137-42

2017 27 11 11

1477-88

2019 99 11 11

1481-94

2017 96 12 12

889-93

2022 23

2021 73 1 1

15-23

2018 54 5 5

663-70

2020 172 5 5

ITC33-48

2023

2022 149 149

2022 2 1 1

1-13

group, on behalf of the guideline development

2022 22 6 6

570-4

2020 18 4 4

459-66

2017 149 10 10

441-8

2024 53

381-9

2020 9 11 11

3564

2022 13

2022 12 1 1

10391

2005 44 11 11

1422-7

2013 33 3 3

743-50

2007 3 1 1

21-4

2023 20 3 3

2261

Fibroactívate Oficial 2022

2020 265

486-95

2002 25 2 2

91-103

2020 34 2 2

242-51

2012 13 6 6

835-42

2021 18 4 4

2075

2020 17 10 10

3634

2022 57

152101

2017 17 65 65

183-204

2021 11th ed.

2020 21 21 21

1-27

2019 24 1 1

17-27

2021 88 5 5

105202

2004 31 9 9

507-13

2021 22 1 1

557

1999 7 2 2

129-61

2020 38 1 1

86-93

Secretaría de Salud 2014

2022 158

104188

2019 23 2 2

382-9

2022 18 2 2

133-40

2019 35

170-6

2022 29

S7-S16

2022 10 12 12

2426

World Medical Association

2013 310 20 20

2191-4

2013 37 6 6

388-93